Drawing for PHARMAFAB

USPTO serial 75848120

PHARMAFAB

Reviewed by CopyMark Law Group

Reg. 2499611Status 710
Filing date
Status date
Registration date
Oct 23, 2001
Examiner
WARD, JOYCE A.
Law office
SCANNING ON DEMAND

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with PHARMAFAB?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Edwin S. Flores

EDWIN S FLORES CHALKER FLORES LLP2711 LBJ FREEWAY, STE 1036DALLAS, TX 75234UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF UPPER RESPIRATORY INFECTIONS, DIGESTIVE SYSTEM DISORDERS, HIGH BLOOD PRESSURE, ARTHRITIS AND LUPUS; COUCH SYRUP, COLD ANALGESICS, PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT IN UPSET STOMACH, PHARMACEUTICALS FOR USE AS SLEEP AIDS, VITAMINS, NUTRITIONAL SUPPLEMENTS; PHARMACEUTICAL PREPARATION AND SUBSTANCES FOR THE PURPOSE OF PAIN CONTROL AND ANESTHESIA; COSMECUETICAL PREPARATIONS FOR USE IN THE TREATMENT OF ACNE, AND NUTRICEUTICALS FOR USE IN THE TREATMENT OF HORMONAL IMBALANCESSECTION 8 - CANCELLEDNov 30, 1994

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 25, 2008C8..CANCELLED SEC. 8 (6-YR)—
Sep 15, 2007CORVREVIEW OF CORRESPONDENCE COMPLETE—
Aug 15, 2007ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Aug 9, 2007FAXXFAX RECEIVED—
Jan 25, 2007CFITCASE FILE IN TICRS—
Nov 18, 2005TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 28, 2005ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 28, 2005REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 23, 2001R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 31, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 18, 2001NPUBNOTICE OF PUBLICATION—
Feb 23, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 13, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 11, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 5, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance